Over the past 20 years, we’ve conducted 53 trials across a wide spectrum of oncology indications, and recruited over 1,000 patients, across 170 sites, in 31 oncology indications. During this time, we have created robust study strategies, establishing a strong presence in Europe, North America and Asia-Pacific.
Our global personnel platform comprises a network of oncologists and in-house specialist clinicians. Their expertise spans across Project Management, Clinical Research Associates (CRAs), Clinical Trial Assistants (CTAs), Medical Writing, Medical Monitoring, Biostatistics, Regulatory Affairs and Data Management. Proficient in every aspect of trial, they have vast experience in the complexities of dose escalation, multiple ascending dose, dose-limiting toxicity models, and adaptive designs.
We’re always looking ahead to what tomorrow could bring. That’s why we are in constant contact with universities, research centers and regulatory agencies all over the world, to help us to keep pushing ahead with the latest oncology innovations, technology and development requirements.
We’re also developing our specialization of oncology research on rare sub types and highly specific inclusion/exclusion criteria.
Relationships with Investigators
Over the years, we’ve forged strong relationships with investigators. These relationships give us an invaluable insight into any potential recruitment challenges and help us to always be one step ahead, allowing us to quickly adapt when necessary.
Key Opinion Leadership
Through 20 years delivering high-quality clinical trials, we have established a network of Key Opinion Leaders (KOLs); critical in bringing new drugs to market.
Below is a full list of areas that we have experience of working in:
- Advanced Breast Cancer
- B-Cell Lymphocytic Leukaemia
- Bladder Cancer
- Colon/Colorectal Cancer/Breast cancer
- Head and Neck Cancer
- Mantle Cell Lymphoma
- Multiple Myeloma
- NSCLC – Non-Small Cell Lung Cancer
- Ovarian Cancer
- Prostate Cancer
- Renal Cell Carcinoma
- Sarcoma and Melanoma
- Solid Tumours and Breast Cancer